Neurocrine Biosciences, Inc. will participate at the 2024 Cantor Global Healthcare Conference in New York at 3:05 p.m. Eastern Time on Tuesday, September 17, 2024. Chief Business Development and ...
The breathing circuits market is projected to grow from USD 1.57 billion in 2024 to USD 2.16 billion by 2029, with a compound ...
Merck has previously tried to improve upon Keytruda with Eisai-partnered VEGFR inhibitor Lenvima in first-line PD-L1-positive NSCLC. In the phase 3 LEAP-007, the doublet led to a statistically ...
Merck’s Keytruda Combo for Urothelial Carcinoma Gets EU Approval: The European Commission granted approval to Merck’s Keytruda in combination with Astellas/Pfizer’s antibody-drug conjugate ...
DoubleVerify (“DV”) (NYSE: DV), a leading software platform for digital media measurement, data and analytics, today announced the rollout of DV’s Inflammatory ...
In particular, Keytruda for cancer represents a key blockbuster ... and the partnerships with AstraZeneca (Lynparza) and Eisai (Lenvima) look like good uses of capital. The Lynparza deal in ...
Intuit (Nasdaq: INTU), the global financial technology platform that makes TurboTax, Credit Karma, QuickBooks, and Mailchimp, will host its annual Investor Day at its headquarters in Mountain View, CA ...
1 First presentation of results from the first interim analysis of the Phase 3 LEAP-012 trial evaluating KEYTRUDA plus LENVIMA in combination with transarterial chemoembolization (TACE ...
Mitchell Kapoor has given his Buy rating due to a combination of factors surrounding the potential of Summit Therapeutics’ drug ivonescimab, particularly in the wake of Merck’s KEYTRUDA failures.
Treatment with lenvatinib (Lenvima) and pembrolizumab (Keytruda) led to significantly longer rates of progression-free survival (PFS) and overall survival (OS) in the phase 3 CLEAR study (NCT02811861) ...
It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...